Skip to main content
. 2017 Jun 24;10(4):546–554. doi: 10.1016/j.tranon.2017.05.007

Supplementary Figure 3.

Supplementary Figure 3

Combination treatment of cell line 402-91 and DL-221 with panobinostat and trabectedin (A and B) showed no synergism or antagonism. Combination therapy of three MLS cell lines with trabectedin and YM155 also demonstrated no synergism or antagonism (C-E).